-
2024-510741-33-00
4
2024-06-27
Macular degeneration
-
2023-505486-92-00
4
2024-02-09
Small bowel adenocarcinoma
-
2022-500391-62-00
9
2023-01-19
Subjects with relapsed/refractory peripheral T-cell lymphoma (R/R PTCL
-
2023-506548-18-00
10
2022-11-10
Dermatitis atopic
-
2024-518195-31-00
6
2021-09-29
acute myocardial infarction
-
2025-522687-33-00
5
2026-05-19
Stroke
-
2024-520205-39-00
5
2026-04-21
Traumatic brain injury
-
2024-510942-15-00
5
2026-04-07
Cancer surgery
-
2024-516643-64-00
5
2026-03-13
Aortic bioprothesis implanted patient for valvular heart disease
-
2023-506725-11-00
5
2026-02-24
Post-aggressive immunosuppression
-
2023-508930-33-00
4
2026-01-30
Non-infectious active cryoglobulinemia vasculitis who are either refra
-
2024-511084-28-00
11
2026-01-12
Hypertrophic Cardiomyopathie
-
2024-519494-19-00
5
2025-12-22
Nutritional and metabolic diseases
-
2025-521710-25-00
4
2025-12-04
Lewy Body Dementia Psychosis (LBDP)
-
2024-510941-32-00
5
2025-12-02
Adult patients discharged alive from ICU with a decreased eGFR, and/or
-
2024-517708-12-00
5
2025-11-07
Severe burns
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2024-511871-13-00
6
2025-10-02
Postmenopausal osteoporosis
-
2024-510943-76-00
5
2025-09-03
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
-
2023-510449-51-00
5
2025-07-31
Adult ICU patients with septic shock
-
2024-516780-93-00
5
2025-07-09
Sustained immunosuppression
-
2023-510262-27-00
4
2025-06-24
newly diagnosed or relapsing deep venous thrombosis related to Behçet’
-
2023-509788-25-00
6
2025-06-16
Rheumatoid arthritis
-
2024-517545-13-00
11
2025-06-04
Neovascular Age-Related Macular Degeneration